Silencing of SRA1 Regulates ER Expression and Attenuates the Growth of Stromal Cells in Ovarian Endometriosis. (June 2017)

• Record Type: Journal Article
• Authors: Lin, Kaiqing; Zhan, Hong; Ma, Junyan; Xu, Kaihong; Wu, Ruijin; Zhou, Caiyun; Lin, Jun
• Is Part Of: Reproductive sciences. Volume 24:Number 6(2017:Jun.)
• Page Start: 836
• Page End: 843
• Publication Date: 2017-06
• Subjects: steroid receptor RNA activator -- steroid receptor RNA activator protein -- estrogen receptor -- ovarian endometriosis -- siRNA; Reproductive health -- Periodicals; Reproduction -- Periodicals; 612.6
• DOI: 10.1177/1933719116670036
• Languages: English
• ISSNs: 1933-7191

Abstract

Estradiol and its nuclear receptors, estrogen receptor (ER) α and ER-β, have important functions in endometriosis, and the transcriptional activity of these receptors is modulated by coactivators and corepressors. The steroid receptor RNA activator 1 (SRA1) produces SRA long noncoding RNA (lncRNA) and SRA protein (SRAP), which regulate ER expression at the RNA and protein levels in some hormone-dependent tumors via an alternative splicing event. However, only a few are reported on their expressions in endometriosis. Here, we observed that low expression levels of SRA lncRNA and ER-α but relatively high expression levels of SRAP and ER-β were detected in ovarian endometriotic tissues versus normal endometrial tissues. Steroid receptor RNA activator 1–small interfering RNA treatment significantly increased ER-α levels but reduced ER-β levels in endometriotic stromal cells (ESCs). Furthermore, the treatment can also attenuate the proliferation and promote early apoptosis in these cells. Our results indicate that the regulation of ER via SRA in ovarian endometriosis may play a significant role in the growth of ESCs.